目次

TABLE OF CONTENT

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 KEY INCLUSIONS & EXCLUSIONS
1.3 RESEARCH SCOPE
1.3.1 SEGMENTS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 MAJOR MARKET STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.3.3 RECESSION IMPACT

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA SOURCES
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.2 MARKET SIZE ESTIMATION METHODOLOGY
2.3 MARKET SHARE ESTIMATION METHODOLOGY
2.4 MARKET BREAK DOWN AND DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 SCOPE RELATED LIMITATIONS
2.6.2 METHODOLOGY RELATED LIMITATIONS
2.7 RISK ASSESSMENT
2.8 RECESSION IMPACT ASSESSMENT APPROACH

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW
5.1 MARKET DYNAMICS
5.1.1 MAJOR DRIVERS
5.1.2 KEY RESTRAINTS
5.1.3 KEY GROWTH OPPORTUNITIES
5.1.4 INDUSTRY-SPECIFIC CHALLENGES
5.2 REGULATORY LANDSCAPE
5.2.1 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
5.2.2 REGULATORY ANALYSIS
5.3 VALUE CHAIN ANALYSIS
5.4 SUPPLY CHAIN ANALYSIS
5.5 ECOSYSTEM MARKET MAP
5.6 TECHNOLOGY ANALYSIS
5.7 TRADE DATA ANALYSIS
5.8 PATENT ANALYSIS
5.9 PORTER’S FIVE FORCE ANALYSIS
5.10 PRICING ANALYSIS
5.10.1 AVERAGE SELLING PRICE OF KEY PLAYERS BY PRODUCT
5.10.2 AVERAGE SELLING PRICE TRENDS
5.11 KEY CONFERENCES AND EVENTS IN 2022-23
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.2 BUYING CRITERIA

6 IGRT MARKET, BY PRODUCT TYPE (USD MILLION; 2021—2028)*
6.1 4D GATING/4D RT
6.2 LINAC (LINEAR ACCELERATOR)
6.3 PET/MRI- GUIDED RADIATION THERAPY
6.4 PORTAL IMAGING
6.5 CT SCANNING

7 IGRT MARKET, BY PROCEDURE (USD MILLION; 2021—2028)*
7.1 INTENSITY-MODULATION RADIATION THERAPY
7.2 3D CONFORMAL RADIATION THERAPY
7.3 STEREOTATIC THERAPY
7.3 PROTON BEAM THERAPY
7.3 PARTICLE THERAPY

8 IGRT MARKET, BY APPLICATION (USD MILLION; 2021—2028)*
8.1 HEAD AND NECK CANCERS
8.2 PROSTATE CANCER
8.3 LUNG CANCER
8.5 BREAST CANCER
8.6 GYNECOLOGICAL CANCERS
8.7 GASTROINTESTINAL CANCERS
8.8 CENTRAL NERVOUS SYSTEM

9 IGRT MARKET, BY END-USER (USD MILLION; 2021—2028)*
9.1 HOSPITALS
9.2 INDEPENDENT RADIOTHERAPY CENTERS

10 IGRT MARKET, BY REGION (USD MILLION; 2021—2028)*
10.1 NORTH AMERICA
10.1.1 RECESSION IMPACT
10.1.2 US
10.1.3 CANADA
10.2 EUROPE
10.2.1 RECESSION IMPACT
10.2.2 GERMANY
10.2.3 UK
10.2.4 FRANCE
10.2.5 ITALY
10.2.6 SPAIN
10.2.7 REST OF EUROPE
10.3 ASIA-PACIFIC
10.3.1 RECESSION IMPACT
10.3.2 JAPAN
10.3.3 CHINA
10.3.4 INDIA
10.3.5 SOUTH KOREA
10.3.6 AUSTRALIA
10.3.7 REST OF ASIA-PACIFIC
10.4 LATIN AMERICA
10.4.1 RECESSION IMPACT
10.4.2 BRAZIL
10.4.3 MEXICO
10.4.4 REST OF LATIN AMERICA
10.5 MIDDLE EAST AND AFRICA
10.5.1 RECESSION IMPACT

11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 REVENUE SHARE ANALYSIS OF KEY PLAYERS (2022)
11.3 MARKET SHARE ANALYSIS FOR TOP 5 GLOBAL PLAYERS (IN TERMS OF %REVENUE, IN 2022)
11.4 COMPANY FOOTPRINT ANALYSIS
11.5 COMPETITIVE BENCHMARKING
11.6 COMPETITIVE SITUATION AND TRENDS (2021-2023)
11.6.1 PRODUCT LAUNCHES
11.6.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
11.6.2 PRODUCT APPROVALS
11.6.2 ACQUISITIONS
11.7 COMPANY EVALUATION QUADRANT
11.7.1 PERVASIVE PLAYERS
11.7.2 EMERGING LEADERS
11.7.3 PARTICIPANTS
11.7.4 STARS
11.8 SME/START-UP EVALUATION QUADRANT
11.8.1 PROGRESSIVE COMPANIES
11.8.2 RESPONSIVE COMPANIES
11.8.3 DYNAMIC COMPANIES
11.8.4 STARTING BLOCKS

12 COMPANY PROFILES**
(Business Overview, Products Offered, Industry-specific Developments for 2021-2023)***
12.1 MAJOR PLAYERS
12.1.1 SIEMENS AG
12.1.2 HITACHI
12.1.3 KONINKLIJKE PHILIPS
12.1.4 ELEKTA
12.1.5 VIEWRAY TECHNOLOGIES INC.
12.1.6 C-RAD
12.1.7 VARIAN MEDICAL SYSTEMS
12.1.8 TOSHIBA CORPORATION
12.1.9 GENERAL ELECTRIC HEALTHCARE COMPANY
12.1.10 IBA WORLWIDE
12.1.11 ACCURACY
12.1.12 BECTON DICKINSON
12.1.13 VISION RT LTD.
12.2 OTHER PLAYERS
12.2.1 ASG SUPERCONDUCTORS
12.2.2 REFLEXION
12.2.3 GALBINO TECHNOLOGY
12.2.4 PANACEA MEDICAL TECHNOLOGY
12.2.5 IZI MEDICAL
12.2.6 XSTRAHL
12.2.7 AEP LINAC

13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS